Indoramin
From Wikipedia, the free encyclopedia
|
Indoramin
|
|
| Systematic (IUPAC) name | |
| N-[1-[2-(1H-indol-3-yl)ethyl]-4-piperidyl]benzamide | |
| Identifiers | |
| CAS number | |
| ATC code | C02 |
| PubChem | |
| Chemical data | |
| Formula | C22H25N3O |
| Mol. mass | 347.454 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Indoramin (trade name Baratol) is a piperidine antiadrenergic agent.
It is an alpha-1 selective adrenoceptor antagonist.[1]
[edit] References
- ^ Pierce V, Shepperson NB, Todd MH, Waterfall JF (February 1986). "Investigation into the cardioregulatory properties of the alpha 1-adrenoceptor blocker indoramin". Br. J. Pharmacol. 87 (2): 433–41. PMID 3955309.
|
||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||

